Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313)
Title:
Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313)
Author:
Sharma, P. Barlow, W.E. Godwin, A.K. Pathak, H. Isakova, K. Williams, D. Timms, K.M. Hartman, A.R. Wenstrup, R.J. Linden, H.M. Tripathy, D. Hortobagyi, G.N. Hayes, D.F.